REG

Regis Healthcare Limited

Healthcare • ASX • Updated August 24, 2026
Analyst Summary
Regis Healthcare operates 72 freehold aged care residences across Australia. We examine the business model, funding structure, competitive position, leadership transition and financial trajectory a...

Thesis

Regis Healthcare is a genuinely well-run business: a 100% freehold aged care portfolio, zero drawn debt, and a capital recycling model that funds growth without touching shareholders' equity. The company owns every bed it operates, carries no debt against a $362 million undrawn facility, and has compounded revenue at double-digit rates for two consecutive years through disciplined, deposit-funded acquisitions. Quality and price are different questions, however, and the current $6.52 share price requires several favourable assumptions, on regulatory funding, on discount rates, and on the pace of acquisition-led growth, to hold simultaneously.

Fair Value Estimate: ██████ Members only

The Business

Regis operates roughly 8,200 aged care beds across 72 freehold residences, making it Australia's second-largest listed operator by bed count. Unlike peers who lease a portion of their portfolio, Regis owns every property outright, which lets it charge premium refundable accommodation deposits (RADs) of around $697,000 versus an industry average closer to $400,000, and removes the lease costs that drag on competitor margins. Roughly 73% of revenue comes from government funding (AN-ACC), with the balance from resident-paid accommodation and services.

Recent Performance

Revenue grew 16.3% in FY26 to $1,351 million, following 14.5% growth the year before, so the acquisitive momentum has been consistent rather than a one-off spike. Despite that top-line strength, EBITDA margin compressed from 10.8% to 10.2% as mandated wage increases outpaced government funding indexation for a third consecutive year. The market has largely looked past this margin pressure in setting the current share price.

Outlook

Revenue growth is set to decelerate materially over the next few years as recent acquisitions annualise and organic bed additions take over as the primary growth driver. Margins are expected to recover over the medium term, helped by a newly legislated RAD retention income stream that allows Regis to keep a portion of resident deposits rather than refund them in full. That stream generated a modest amount in its first eight months and is targeted to scale meaningfully by year three, though it remains unproven at scale.

Key Risks

Inadequate government funding indexation is the central risk to the thesis. Should October's AN-ACC pricing decision disappoint, consistent with the pattern of the last three years, the margin recovery case weakens considerably, since staff costs are largely mandated while government pricing sets the majority of revenue. A housing market correction poses a secondary risk: most incoming residents fund their deposit by selling a family home, so a sustained downturn would slow the deposit inflows that finance growth. The simultaneous departure of both the CEO and CFO adds execution risk during a period that demands leadership continuity, particularly given the timing alongside the funding decision and ongoing acquisition integration.

What to Watch

  • October 2026 AN-ACC pricing announcement — the thesis-defining event. A strong increase would validate the margin recovery case, while an outcome consistent with the last three years would confirm the funding shortfall is structural rather than temporary.
  • 2-3 years RAD retention income scaling — confirms whether the new revenue stream is delivering at scale rather than remaining a rounding error.
Reassess Valuation If
The October 2026 AN-ACC pricing decision comes in well above recent history and RAD retention income scales meaningfully faster than plan by the first half of FY27.
Exit/Reduce If
A second C-suite departure occurs within 12 months, or the staff cost ratio rises to an elevated share of revenue for two consecutive quarters.
Investment Rating: ██████ Members only

Business

Company Description

Regis Healthcare is a pure-play residential aged care operator, generating over 95% of revenue from around 8,200 beds across 72 wholly-owned, freehold facilities. A small home care and retirement living segment contributes roughly 3% of revenue and is not a strategic focus. Government funding under the AN-ACC pricing model covers approximately 73% of revenue, with the remainder from resident accommodation deposits, daily fees, and additional services. The business is funded not by debt but by refundable accommodation deposits: cash residents pay upfront and largely refund on departure, which Regis recycles into new beds and acquisitions.

Where the Growth Is

The single biggest swing factor over the next three years is RAD retention income, a new revenue stream legislated from November 2025 that allows Regis to keep a portion of resident deposits rather than refund the full amount. It generated just $1.3 million in its first eight months but is targeted to scale toward $30-50 million annually by year three. If achieved, this would meaningfully lift EBITDA margin over the following few years without requiring a single additional bed. The gap between the current run-rate and the target is wide, which makes this the key variable to track rather than a settled input.

Competitive Position

Regis's advantage rests on owning its entire portfolio outright, a structure none of its scaled competitors match. This drives higher resident deposits ($697,000 versus roughly $400,000 industry-wide) and removes the lease expense that compresses lessee-operator margins. Australia needs an estimated 10,000 new aged care beds annually but is adding fewer than 800, a structural shortage that supports the 96% occupancy Regis reports across its mature portfolio. These advantages are real but not impenetrable: government sets most of the pricing, and the moat depends on continued access to capital and acquisition discipline rather than a hard-to-replicate technology or brand. The advantage is widening as more freehold sites become scarce, but it will take years, not quarters, to become decisive.

Management & Capital Discipline

Management has completed four acquisitions at disciplined multiples of 8-9 times EBITDA, funding all of them through resident deposit inflows rather than drawn debt, a genuinely conservative approach to growth. Operational execution has been strong: occupancy sits at 96% and staff turnover has fallen from 23% to 18%. The uncomfortable truth is that both the CEO and CFO are departing within weeks of each other, right as the company navigates the most consequential funding decision in years. That is not a hypothetical risk; it is a leadership vacuum during a period that demands continuity.

Financial Position

Regis carries zero drawn debt and holds $362 million in undrawn facilities on top of existing cash, giving it multi-year liquidity headroom regardless of how the funding environment evolves. This balance sheet strength is the clearest offsetting factor against the regulatory and leadership risks noted above: the company can absorb a prolonged funding shortfall or a housing-driven slowdown in deposit inflows without financial distress, even if profitability disappoints.

Read the full report

Our complete analysis of Regis Healthcare Limited includes:

Financial estimates DCF valuation Fair value & scenarios Investment rating
Subscribe